缺血性中风的治疗管理
Priya Bindal1, Vishal Kumar1, Lakshay Kapil1
1Department of Pharmacology, ISF College of Pharmacy, Moga 142001, Affiliated to I.K Gujral Punjab Technical University, Jalandhar, Punjab, India.
Naunyn-Schmiedeberg's archives of pharmacology
|November 15, 2023
概括
脑卒中是导致残疾和死亡的首要原因,治疗选择正在扩大. 最近的进展和新的治疗方法,如迷走神经刺激,为中风患者提供了新的希望.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 再生医学是一种再生医学.
背景情况:
- 脑卒中是全球死亡和残疾的主要原因之一.
- 缺血性中风 (动脉堵塞) 和出血性中风 (脑出血) 是主要类型.
- 阿尔特普拉斯是FDA批准的唯一用于缺血性中风的血栓溶解疗法.
研究的目的:
- 审查关于中风诊断,评估和管理的当前理解和临床研究.
- 探索中风的过去,现在和未来的治疗策略.
- 专注于中风病原性,最近的进展和潜在的治疗点.
主要方法:
- 在PubMed和Google Scholar的文献搜索中寻找治疗方案.
- 临床研究的审查和关于中风管理的当前观点.
- 对内血管治疗和静脉静脉血栓溶解方面的进展进行分析.
主要成果:
- 自1995年至2015年以来,缺血性中风的治疗选择显著扩大.
- 像迷走神经刺激这样的新方法显示出潜在的显著患者益处.
- 治疗性低温是一种强大的神经保护剂,具有确定的临床和临床前疗效.
结论:
- 快速介入中风与改善的临床结果有关.
- 未来的中风治疗可能涉及到超越传统方法的创新方法.
- 了解中风病原性对于开发有效的治疗点至关重要.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Atherosclerosis IV: Nursing Management
17
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
17
Angina IV: Management
9
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
9
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9


